A novel role for the bactericidal/permeability increasing protein in interactions of gram-negative bacterial outer membrane blebs with dendritic cells

Journal of Immunology

Volumn 179, Issue 4, 2007, Pages 2477-2484

  Schultz, Hendrik ^a,b   Hume, Janet ^a,c   De, Sheng Zhang ^b   Gioannini, Theresa L ^a,b   Weiss, Jerrold P ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID C 14; B7 ANTIGEN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; ENDOTOXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; LIPOPOLYSACCHARIDE BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OUTER MEMBRANE PROTEIN; RADIOISOTOPE; RANTES; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL ANTIGEN; CARRIER PROTEIN; CHEMOKINE; HLA ANTIGEN CLASS 2; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN; PLASMA PROTEIN;

ARTICLE; BACTERICIDAL ACTIVITY; CELL FREE SYSTEM; CONTROLLED STUDY; DENDRITIC CELL; FLUORESCENCE; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE; MEMBRANE VESICLE; MONOCYTE; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ACTIVE TRANSPORT; ANTIGEN PRESENTATION; CELL CULTURE; CELL MEMBRANE; IMMUNOLOGY; METABOLISM; PROTEIN BINDING; SECRETION;

ACUTE-PHASE PROTEINS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD PROTEINS; CARRIER PROTEINS; CELL MEMBRANE; CELLS, CULTURED; CHEMOKINES; DENDRITIC CELLS; ENDOTOXINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNITY, NATURAL; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; NEISSERIA MENINGITIDIS, SEROGROUP B; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 34848888451     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.4.2477     Document Type: Article

References (58)

1. Weiss, J. 2003. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochem. Soc. Trans. 31: 785-790.
2. Beamer, L. J., S. F. Carroll, and D. Eisenberg. 1998. The BPI/LBP family of proteins: a structural analysis of conserved regions. Protein Sci. 7: 906-914.
3. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249: 1429-1431.
4. Munford, R. S. 2005. Detoxifying endotoxin: time, place and person. J. Endotoxin Res. 11: 69-84.
5. Alexander, C., and E. T. Rietschel. 2001. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7: 167-202.
6. Gioannini, T. L., A. Teghanemt, D. Zhang, E. N. Levis, and J. P. Weiss. 2005. Monomeric endotoxin:protein complexes are essential for TLR4-dependent cell activation. J. Endotoxin Res. 11: 117-123.
7. Prohinar, P., F. Re, R. Widstrom, D. Zhang, A. Teghanemt, J. P. Weiss, and T. L. Gioannini. 2007. Specific high affinity interactions of monomeric endotoxin: protein complexes with Toll-like receptor 4 ectodomain. J. Biol. Chem. 282: 1010-1017.
8. Beutler, B., Z. Jiang, P. Georgel, K. Crozat, B. Croker, S. Rutschmann, X. Du, and K. Hoebe. 2006. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24: 353-389.
9. Weiss, J., P. Elsbach, I. Olsson, and H. Odeberg. 1978. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J. Biol. Chem. 253: 2664-2672.
10. Canny, G., O. Levy, G. T. Furuta, S. Narravula-Alipati, R. B. Sisson, C. N. Serhan, and S. P. Colgan. 2002. Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc. Natl. Acad. Sci. USA 99: 3902-3907.
11. Reichel, P. H., C. Seemann, E. Csernok, J. M. Schroder, A. Muller, W. L. Gross, and H. Schultz. 2003. Bactericidal/permeability-increasing protein is expressed by human dermal fibroblasts and upregulated by interleukin 4. Clin. Diagn. Lab. Immunol. 10: 473-475.
12. Calafat, J., H. Janssen, A. Tool, M. A. Dentener, E. F. Knol, H. F. Rosenberg, and A. Egesten. 1998. The bactericidal/permeability-increasing protein (BPI) is present in specific granules of human eosinophils. Blood 91: 4770-4775.
13. Mannion, B. A., J. Weiss, and P. Elsbach. 1990. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. J. Clin. Invest. 86: 631-641.
14. Marra, M. N., C. G. Wilde, J. E. Griffith, J. L. Snable, and R. W. Scott. 1990. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. J. Immunol. 144: 662-666.
15. Katz, S. S., K. Chen, S. Chen, M. E. Doerfler, P. Elsbach, and J. Weiss. 1996. Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin. Infect. Immun. 64: 3592-3600.
16. 2-terminal fragment cause killing of serum-resistant Gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J. Clin. Invest. 90: 1122-1130.
17. Iovine, N., J. Eastvold, P. Elsbach, J. P. Weiss, and T. L. Gioannini. 2002. The carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexes. J. Biol. Chem. 277: 7970-7978.
18. Iovine, N. M., P. Elsbach, and J. Weiss. 1997. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. Proc. Natl. Acad. Sci. USA 94: 10973-10978.
19. von der Mohlen, M. A., A. N. Kimmings, N. I. Wedel, M. L. Mevissen, J. Jansen, N. Friedmann, T. J. Lorenz, B. J. Nelson, M. L. White, R. Bauer, et al. 1995. Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein. J. Infect. Dis. 172: 144-151.
20. Giroir, B. P., P. A. Quint, P. Barton, E. A. Kirsch, L. Kitchen, B. Goldstein, B. J. Nelson, N. J. Wedel, S. F. Carroll, and P. J. Scannon. 1997. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet 350: 1439-1443.
21. Demetriades, D., J. S. Smith, L. E. Jacobson, M. Moncure, J. Minei, B. J. Nelson, and P. J. Scannon. 1999. Bactericidal/permeability-increasing protein (rBPI21) in patients with hemorrhage due to trauma: results of a multicenter phase II clinical trial. rBPI21 Acute Hemorrhagic Trauma Study Group. J. Trauma. 46: 667-676.
22. Bauer, R. J., M. L. White, N. Wedel, B. J. Nelson, N. Friedmann, A. Cohen, W. N. Hustinx, and A. H. Kung. 1996. A phase I safety and pharmacokinetic study of a recombinant amino terminal fragment of bactericidal/permeability- increasing protein in healthy male volunteers. Shock 5: 91-96.
23. Devoe, I. W., and J. E. Gilchrist. 1973. Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J. Exp. Med. 138: 1156-1167.
24. Munford, R. S., C. L. Hall, J. M. Lipton, and J. M. Dietschy. 1982. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J. Clin. Invest. 70: 877-888.
25. Beveridge, T. J. 1999. Structures of Gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 181: 4725-4733.
26. Giardina, P. C., T. Gioannini, B. A. Buscher, A. Zaleski, D. S. Zheng, L. Stoll, A. Teghanemt, M. A. Apicella, and J. Weiss. 2001. Construction of acetate auxotrophs of Neisseria meningitidis to study host-meningococcal endotoxin interactions. J. Biol. Chem. 276: 5883-5891.
27. Post, D. M., D. Zhang, J. S. Eastvold, A. Teghanemt, B. W. Gibson, and J. P. Weiss. 2005. Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B. J. Biol. Chem. 280: 38383-38394.
28. Thompson, C. R., S. S. Iyer, N. Melrose, R. VanOosten, K. Johnson, S. M. Pitson, L. M. Obeid, and D. J. Kusner. 2005. Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: inhibition of SK1 translocation by Mycobacterium tuberculosis. J. Immunol. 174: 3551-3561.
29. Herrmann, T. L., C. T. Morita, K. Lee, and D. J. Kusner. 2005. Calmodulin kinase II regulates the maturation and antigen presentation of human dendritic cells. J. Leukocyte Biol. 78: 1397-1407.
30. Weinrauch, Y., S. S. Katz, R. S. Munford, P. Elsbach, and J. Weiss. 1999. Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate. Infect. Immun. 67: 3376-3382.
31. Schulert, G. S., and L. A. Allen. 2006. Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor. J. Leukocyte Biol. 80: 563-571.
32. + monocytes: molecular determinants and fate of endotoxin. Thesis, University of Iowa, Iowa City, Iowa.
33. Opal, S. M., J. E. Palardy, M. N. Marra, C. J. Fisher, Jr., B. M. McKelligon, and R. W. Scott. 1994. Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet 344: 429-431.
34. Lu, M., M. Zhang, R. L. Kitchens, S. Fosmire, A. Takashima, and R. S. Munford. 2003. Stimulus-dependent deacylation of bacterial lipopolysaccharide by dendritic cells. J. Exp. Med. 197: 1745-1754.
35. Pavli, P., D. A. Hume, E. Van De Pol, and W. F. Doe. 1993. Dendritic cells, the major antigen-presenting cells of the human colonic lamina propria. Immunology 78: 132-141.
36. Pavli, P., L. Maxwell, E. van de Pol, and W. F. Doe. 1995. Distribution of human colonic dendritic cells and macrophages-functional implications. Adv. Exp. Med. Biol. 378: 121-123.
37. Holt, P. G. 2005. Pulmonary dendritic cells in local immunity to inert and pathogenic antigens in the respiratory tract. Proc. Am. Thorac. Soc. 2: 116-120.
38. Ruppert, J., C. Schutt, D. Ostermeier, and J. H. Peters. 1993. Down-regulation and release of CD14 on human monocytes by IL-4 depends on the presence of serum or GM-CSF. Adv. Exp. Med. Biol. 329: 281-286.
39. Heumann, D., P. Gallay, S. Betz-Corradin, C. Barras, J. D. Baumgartner, and M. P. Glauser. 1993. Competition between bactericidal/permeability- increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes. J. Infect. Dis. 167: 1351-1357.
40. Gazzano-Santoro, H., K. Meszaros, C. Birr, S. F. Carroll, G. Theofan, A. H. Horwitz, E. Lim, S. Aberle, H. Kasler, and J. B. Parent. 1994. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and Gram-negative bacteria. Infect. Immun. 62: 1185-1191.
41. Gazzano-Santoro, H., J. B. Parent, L. Grinna, A. Horwitz, T. Parsons, G. Theofan, P. Elsbach, J. Weiss, and P. J. Conlon. 1992. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect. Immun. 60: 4754-4761.
42. Mannion, B. A., E. S. Kalatzis, J. Weiss, and P. Elsbach. 1989. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria: implications and use as a means of purification. J. Immunol. 142: 2807-2812.
43. Unkmeir, A., U. Kammerer, A. Stade, C. Hubner, S. Haller, A. Kolb-Maurer, M. Frosch, and G. Dietrich. 2002. Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells. Infect. Immun. 70: 2454-2462.
44. Weinrauch, Y., A. Foreman, C. Shu, K. Zarember, O. Levy, P. Elsbach, and J. Weiss. 1995. Extracellular accumulation of potently microbicidal bactericidal/ permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J. Clin. Invest. 95: 1916-1924.
45. Bsibsi, M., J. J. Bajramovic, E. Van Duijvenvoorden, C. Persoon, R. Ravid, J. M. Van Noort, and M. H. Vogt. 2007. Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins. Glia 55: 473-482.
46. Dixon, G. L., P. J. Newton, B. M. Chain, D. Katz, S. R. Andersen, S. Wong, P. van der Ley, N. Klein, and R. E. Callard. 2001. Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria. Infect. Immun. 69: 4351-4357.
47. Al-Bader, T., K. A. Jolley, H. E. Humphries, J. Holloway, J. E. Heckels, A. E. Semper, P. S. Friedmann, and M. Christodoulides. 2004. Activation of human dendritic cells by the PorA protein of Neisseria meningitidis. Cell Microbiol. 6: 651-662.
48. Lehmann, A. K., A. Halstensen, I. S. Aaberge, J. Holst, T. E. Michaelsen, S. Sørnes, L. M. Wetzler, and H.-K. Guttormsen. 1999. Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infect. Immun. 67: 2552-2560.
49. Bjerre, A., B. Brusletto, T. E. Mollnes, E. Fritzsønn, E. Rosenqvist, E. Wedege, E. Namork, P. Kierulf, and P. Brandtzaeg. 2002. Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant. J. Infect. Dis. 185: 220-228.
50. Brandtzaeg, P. 2003. Host response to Neisseria meningitidis lacking lipopolysaccharides. Expert Rev. Anti Infect. Ther. 1: 589-596.
51. Sprong, T., A.-S. Møller, A. Bjerre, E. Wedege, P. Kierulf, J. W. van der Meer, P. Brandtzaeg, M. van Deuren, and T. E. Mollnes. 2004. Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide. Infect. Immun. 72: 3344-3349.
52. Lu, M., M. Zhang, A. Takashima, J. Weiss, M. A. Apicella, X. H. Li, D. Yuan, and R. S. Munford. 2005. Lipopolysaccharide deacylation by an endogenous lipase controls innate antibody responses to Gram-negative bacteria. Nat. Immunol. 6: 989-994.
53. Blander, J. M., and R. Medzhitov. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
54. Prohinar, P. 2003. Responses of Escherichia coli to the neutrophil bactericidal/ permeability-increasing protein. Thesis, University of Iowa, Iowa City, Iowa.
55. Gioannini, T. L., A. Teghanemt, D. Zhang, N. P. Coussens, W. Dockstader, S. Ramaswamy, and J. P. Weiss. 2004. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl. Acad. Sci. USA 101: 4186-4191.
56. Zhao, M. H., D. R. Jayne, L. G. Ardiles, F. Culley, M. E. Hodson, and C. M. Lockwood. 1996. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM. 89: 259-265.
57. Stoffel, M. P., E. Csernok, C. Herzberg, T. Johnson, S. F. Carroll, and W. L. Gross. 1996. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin. Exp. Immunol. 104: 54-59.
58. Schultz, H., S. Schinke, J. Weiss, V. Cerundolo, W. L. Gross, and S. Gadola. 2003. BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections. Clin. Exp. Immunol. 133: 252-259.